Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice

Fig. 3

Distribution of patients for the relation between Hemoglobin A1c (HbA1c) and body weight before and after treatment with short-acting exenatide over 20 weeks. Red line represents regression for HbA1c according to body weight change, which shows the correlation coefficient as 0.00357 closed to 0. It means that there is rare correlation between changes HbA1c and body weight

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us